Emerson Electric Co: Form 10-Q for the period ended Mar 31, 2026
Filed with the SEC on May 5, 2026 and accepted by EDGAR at May 5, 2026, 16:08 ET.
Management's discussion and analysis
As filed, 767 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
| Period | Total Number of Shares Purchased (000s) | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (000s) | Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs (000s) |
|---|---|---|---|---|
| January 2026 | 100 | $146.37 | 100 | 67,617 |
| February 2026 | 1,341 | $149.31 | 1,341 | 66,276 |
| March 2026 | 581 | $136.27 | 581 | 65,695 |
| Total | 2,022 | $145.41 | 2,022 | 65,695 |
In November 2025, the Board of Directors authorized the purchase of up to 50 million shares. This is in addition to the authorization approved by the Board in March 2020 for the purchase of up to 60 million shares. Approximately 65.7 shares remain available at March 31, 2026.
Market risk
As filed, 340 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There has been no significant change in our exposure to market risk during the three and six months ended March 31, 2026. For a discussion of our exposure to market risk, refer to Item 7A, "Quantitative and Qualitative Disclosures about Market Risk," contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2025.
Controls and procedures
As filed, 1,196 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The Company maintains a system of disclosure controls and procedures designed to ensure that information required to be disclosed in its reports under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported in a timely manner. This system also is designed to ensure information is accumulated and communicated to management, including the Company's certifying officers, to allow timely decisions regarding required disclosure. Based on an evaluation performed, the certifying officers have concluded that the disclosure controls and procedures were effective as of the end of the period covered by this report.
Notwithstanding the foregoing, there can be no assurance that the Company's disclosure controls and procedures will detect or uncover all failures of persons within the Company and its consolidated subsidiaries to report material information otherwise required to be set forth in the Company's reports.
There was no change in the Company's internal control over financial reporting during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2026-01-01 to 2026-03-31 | $4.56bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2025-10-01 to 2026-03-31 | $8.91bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2026-01-01 to 2026-03-31 | $2.14bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2025-10-01 to 2026-03-31 | $4.17bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2026-01-01 to 2026-03-31 | $1.32bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2025-10-01 to 2026-03-31 | $2.56bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Income tax | 3 months2026-01-01 to 2026-03-31 | $175.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2025-10-01 to 2026-03-31 | $344.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2026-01-01 to 2026-03-31 | $618.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2025-10-01 to 2026-03-31 | $1.22bn | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months2026-01-01 to 2026-03-31 | 563,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2025-10-01 to 2026-03-31 | 563,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2025-10-01 to 2026-03-31 | $1.48bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2025-10-01 to 2026-03-31 | $182.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2025-10-01 to 2026-03-31 | $624.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2025-10-01 to 2026-03-31 | $542.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2026-03-31 | $9.25bn | us-gaap:AssetsCurrent |
| Total assets | At period end2026-03-31 | $42.09bn | us-gaap:Assets |
| Current liabilities | At period end2026-03-31 | $10.65bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2026-03-31 | $7.55bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2026-03-31 | $5.80bn | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2026-03-31 | $20.30bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2026-03-31 | 560,100,000 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000032604-26-000035. Last ingested by Listed: Nov 6, 2026, 17:15 ET. Listed shows no prices and gives no investment advice.